Daniel A Engel

Title: The Innovations of Daniel A Engel

Introduction

Daniel A Engel is a notable inventor based in Charlottesville, VA (US). He has made significant contributions to the field of biotechnology, particularly in the development of recombinant antibodies. His work focuses on addressing critical health challenges, such as those posed by the Ebola virus.

Latest Patents

Daniel A Engel holds a patent for "Recombinant antibodies that recognize the C-terminal domains of Ebola virus nucleoprotein." This patent is directed towards compositions and methods that utilize the boundaries of the C-terminal domains of Nucleoprotein from the Zaire Ebola virus. These highly stable recombinant protein antigens are designed to generate antibodies for the diagnosis and treatment of Ebola virus infection. He has 1 patent to his name.

Career Highlights

Throughout his career, Engel has been associated with prestigious institutions, including the University of Virginia Patent Foundation and The University of Chicago. His work has been instrumental in advancing the understanding and treatment of viral infections.

Collaborations

Engel has collaborated with esteemed colleagues such as Zygmunt S Derewenda and Anthony A Kossiakoff. Their combined expertise has contributed to the success of his research and innovations.

Conclusion

Daniel A Engel's contributions to biotechnology and his innovative patent on recombinant antibodies highlight his commitment to improving health outcomes. His work continues to inspire advancements in the field of medical research.